Downregulation of MICA/B tumor surface expressions and augmented soluble MICA serum levels correlate with disease stage in breast cancer
Breast Disease · 06.01.2023 · 41 (1) · 471-480
DOI: 10.3233/bd-220023 ↗Kurz gefasst
Fachartikel in der Zeitschrift Breast Disease, erschienen am 06.01.2023. Verfasst von Jeevitaa Kshersagar und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Stem Cells & Regenerative Medicine, D. Y. Patil Deemed to be University, D. Y. Patil Vidyanagar, Kasba Bawda, Kolhapur, Maharashtra, In…. Hauptthemen laut MEDLINE: Breast Neoplasms. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 24 Literaturangaben.
Abstract (Originalsprache)
OBJECTIVE: In this study, the profiling of the expression of major histocompatibility complex (MHC) class I-related chain A and B (MICA/B) in human breast cancer tumor tissue, saliva, and urine samples of breast cancer patients and control is carried out. MICA/B is ligand of NKG2D receptor expressed on malignant cells. The release of MICA/B from tumor tissue comprises an immune escape mechanism that impairs antitumor immunity. Based on this literature we explored the potential of soluble MICA (sMICA) as a marker in breast cancer (BC). METHODS: The expression was profiled by using immunohistochemistry (MICA/B), western blot (MICA/B) and ELISA (MICA). RESULTS: The optical density of western blot of MICA/B in different stages of BC illustrated significant difference as per one way analysis of variance and significant difference with stage III and IV by Dunnett’s multiple comparisons test respectively. Analysis of sMICA in serum, saliva and urine of BC patients revealed significantly higher levels (median 41.0 ± 4.1 pg/ml in pre-treatment sera, 181.9 ± 1.6 pg/ml in saliva and 90.7 ± 1.7 pg/ml in urine) than in control (median
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Stem Cells & Regenerative Medicine, D. Y. Patil Deemed to be University, D. Y. Patil Vidyanagar, Kasba Bawda, Kolhapur, Maharashtra, India.
- Stem Plus Biotech, SMK Commercial Complex, Near Shivaji Maharaj Putla, Gaon Bhag, Sangli, Maharashtra, India.
- Department of Pathology, Shri Siddhivinayak Ganpati Cancer Hospital, Miraj, Sangli, Maharashtra, India.
- Department of Statistics, Yashavantrao Chavan Institute of Science, Satara, Maharashtra, India.
- Department of Scientific and Industrial Research Organization, Shri Siddhivinayak Ganpati Cancer Hospital, Miraj, Sangli, Maharashtra, India.
- Department of Obstetrics and Gynaecology, Dr. D Y Patil Medical College, Hospital and Research Institute, Kadamwadi, Kolhapur, Maharashtra, India.
Zitieren
APA
Kshersagar, J., Damle, M. N., Bedge, P., Jagdale, R., Tardalkar, K., Jadhav, D., Jagadale, S., Toro, Y., Sharma, R., & Joshi, M. G. (2023). Downregulation of MICA/B tumor surface expressions and augmented soluble MICA serum levels correlate with disease stage in breast cancer. Breast Disease, 41(1), 471-480. https://doi.org/10.3233/bd-220023
Vancouver
Kshersagar J, Damle MN, Bedge P, Jagdale R, Tardalkar K, Jadhav D, et al. Downregulation of MICA/B tumor surface expressions and augmented soluble MICA serum levels correlate with disease stage in breast cancer. Breast Disease. 2023;41(1):471-480. doi:10.3233/bd-220023
BibTeX
@article{Kshersagar2023,
author = {Kshersagar, Jeevitaa and Damle, Mrunal N and Bedge, Poonam and Jagdale, Rakhi and Tardalkar, Kishor and Jadhav, Dhanaji and Jagadale, Swapnali and Toro, Yashwant and Sharma, Rakesh and Joshi, Meghnad G},
title = {Downregulation of MICA/B tumor surface expressions and augmented soluble MICA serum levels correlate with disease stage in breast cancer},
journal = {Breast Disease},
year = {2023},
volume = {41},
number = {1},
pages = {471--480},
doi = {10.3233/bd-220023}
}
EUVIMED